SCHEMBL331846

SCHEMBL331846

CCCCCCCCCCCC[N+](CCCC)(CCCC)CCCCCCCCCCCC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.93
ALDH1A1 P00352 1/20 0.87
TP53 P04637 1/20 0.87
CYP3A4 P08684 1/20 0.87
ALOX15 P16050 1/20 0.87
TSHR P16473 1/20 0.87
ALOX12 P18054 1/20 0.87
SMN1; SMN2 Q16637 1/20 0.87
HIF1A Q16665 1/20 0.87
HSD17B10 Q99714 1/20 0.87
SLC22A2 O15244 1/20 0.86
DNM1 Q05193 8/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL332169 1.00 SLC22A1 (0.93) SLC22A1ALDH1A1TP53CYP3A4ALOX15
SCHEMBL2547248 1.00 SLC22A1 (0.93) SLC22A1ALDH1A1TP53CYP3A4ALOX15
SCHEMBL1010199 1.00 SLC22A1 (0.93) SLC22A1ALDH1A1TP53CYP3A4ALOX15
SCHEMBL1063837 1.00 SLC22A1 (0.93) SLC22A1ALDH1A1TP53CYP3A4ALOX15
SCHEMBL5294280 1.00 SLC22A1 (0.93) SLC22A1ALDH1A1TP53CYP3A4ALOX15
SCHEMBL15536827 1.00 SLC22A1 (0.93) SLC22A1ALDH1A1TP53CYP3A4ALOX15
SCHEMBL16390862 1.00 SLC22A1 (0.93) SLC22A1ALDH1A1TP53CYP3A4ALOX15
SCHEMBL3215351 1.00 SLC22A1 (0.93) SLC22A1ALDH1A1TP53CYP3A4ALOX15
SCHEMBL1062330 1.00 SLC22A1 (0.93) SLC22A1ALDH1A1TP53CYP3A4ALOX15
SCHEMBL5288910 1.00 SLC22A1 (0.93) SLC22A1ALDH1A1TP53CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1846152-A1 STABILIZED CRYSTALLIZED CATANIONIC NANODISCS, METHOD FOR PREPARING SAME AND USES THEREOF COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2007-10-24 EP claimed
EP-1718406-A1 POLYMER-STABILISED, CRYSTALLISED, CATANIONIC MEMBRANES, PREPARATION METHOD THEREOF AND APPLICATIONS OF SAME COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2006-11-08 EP claimed
WO-2006070095-A1 STABILIZED CRYSTALLIZED CATANIONIC NANODISCS, METHOD FOR PREPARING SAME AND USES THEREOF COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2006-07-06 WO claimed
WO-2005089927-A1 POLYMER-STABILISED, CRYSTALLISED, CATANIONIC MEMBRANES, PREPARATION METHOD THEREOF AND APPLICATIONS OF SAME COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2005-09-29 WO claimed
US-12378358-B2 Resin composition, molded body, and their application MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-08-05 US disclosed
US-20250122418-A1 Synergistic Blends Of Anti-Agglomerant Gas Hydrate Inhibitors With Quaternary Alkyl Ammonium Compounds CLARIANT INT LTD (CH) 2025-04-17 US disclosed
US-12129427-B2 Synergistic blends of anti-agglomerant gas hydrate inhibitors with quaternary alkyl ammonium compounds CLARIANT INTERNATIONAL LTD (CH) 2024-10-29 US disclosed
US-20240182640-A1 Resin Composition, Molded Body, And Their Application MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-06-06 US disclosed
US-11981809-B2 Stretched body, PET bottle, and method for producing container MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-05-14 US disclosed
US-11898091-B2 Synergistic blends of anti-agglomerant gas hydrate inhibitors with quaternary benzyl ammonium compounds CLARIANT INTERNATIONAL LTD (CH) 2024-02-13 US disclosed
CN-112771117-B Method for manufacturing stretched body, plastic bottle and container 三菱瓦斯化学株式会社 2023-06-02 CN disclosed
CN-112739779-B Resin composition, molded article, and use thereof 三菱瓦斯化学株式会社 2023-02-21 CN disclosed
WO-2003051781-A1 DETOXIFICATION OF QUATERNARY ONIUM COMPOUNDS WITH POLYCARBOXYLATE CONTAINING COMPOUND BAKER HUGHES INCORPORATED (US) 2003-06-26 WO disclosed
US-20030114591-A1 Polyamide resin composition MITSUBISHI GAS CHEMICAL COMPANY (JP) 2003-06-19 US disclosed
EP-1308478-A1 Polyamide resin composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2003-05-07 EP disclosed
US-6515099-B2 Preventing thermal degradation and gelation by regulating the melt-kneading of a m-xylylenediamine/acyclic dicarboxylic acid-based polyamide and a layered silicate treated with an organic swelling agent; packaging foods; films; barriers MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2003-02-04 US disclosed
WO-2002066785-A1 COMPOSITION AND METHOD FOR INHIBITION OF FORMATION OF GAS HYDRATES BAKER HUGHES INCORPORATED (US) 2002-08-29 WO disclosed
US-20020038063-A1 Composition and method for inhibition of formation of gas hydrates BAKER HUGHES INCORPORATED 2002-03-28 US disclosed
US-20010056148-A1 Shaped article of polyamide resin and production thereof MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2001-12-27 US disclosed
EP-1156073-A1 Shaped article of polyamide resin and production thereof MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2001-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12129427-B2 Synergistic blends of anti-agglomerant gas hydrate inhibitors with quaternary alkyl ammonium compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, RCC1, MTDH SLC22A1 709/4885ALDH1A1 3129/4885TP53 1612/4885
US-11898091-B2 Synergistic blends of anti-agglomerant gas hydrate inhibitors with quaternary benzyl ammonium compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, RCC1, AQP1 SLC22A1 644/4885ALDH1A1 3641/4885TP53 2433/4885
US-20250122418-A1 Synergistic Blends Of Anti-Agglomerant Gas Hydrate Inhibitors With Quaternary Alkyl Ammonium Compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HDHD5, AQP1 SLC22A1 690/4885ALDH1A1 3650/4885TP53 647/4885
US-20020038063-A1 Composition and method for inhibition of formation of gas hydrates HDHD5, SHH, NOTUM SLC22A1 2116/4885ALDH1A1 4272/4885TP53 2953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.